MedPath

Effect of Colloid Versus Crystalloid on Coagulation

Phase 4
Conditions
Bloodloss
Interventions
Drug: Ringer-lactate "SAD"
Registration Number
NCT01444508
Lead Sponsor
K. C. Rasmussen
Brief Summary

In order to reduce bloodloss and need for transfusion to investigate the effect of colloid and crystalloid on coagulation assuming no difference between the groups.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Patient more than 18 years old
  • Indication for elective post-renal operation including cystectomy
  • Patient without anticoagulative, acetylsalicylic acid or NSAID treatment for the last 5 days.
Exclusion Criteria
  • Intracerebral bleeding, manifest cardiac insufficient, renal insufficient demanding dialysis, hepatic or coagulation diseases
  • Pregnant or nursing
  • Allergic
  • Disturbance in electrolytes
  • Patient under committee
  • Patient joining another trial interfering the actual trial.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
crystalloidRinger-lactate "SAD"-
colloidHES 130/04-
Primary Outcome Measures
NameTimeMethod
Effect of colloid versus crystalloid on laboratory coagulation.5-7 hours

Coagulation is analysed in bloodsamples before, during (10 minutes post cystectomia), at the end of the operation and 2 hours later on.

The bloodsamples are analysed by thromboelastography (5000 series TEG analyzer, Haemoscope Corporation, Niles IL, USA) besides the classic coagulation parametres: platelet count, INR, Fibrinogen, APTT, D-dimer and Haemoglobin, Amylase and Creatinin.

Secondary Outcome Measures
NameTimeMethod
Effect of colloid versus crystalloid on the amount of bloodloss5-7 hours

The water balance inclusive the amount of bloodloss is registrated at the end of the operation and 2 hours later on.

Trial Locations

Locations (1)

Rigshospitalet

🇩🇰

Copenhagen, Denmark

© Copyright 2025. All Rights Reserved by MedPath